VIGIL NEUROSCIENCE INC's ticker is and the CUSIP is 92673K108. A total of 47 filers reported holding VIGIL NEUROSCIENCE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $179 | -53.6% | 44,755 | -60.4% | 0.00% | – |
| Q1 2024 | $386 | -7.9% | 113,036 | -8.7% | 0.00% | – |
| Q4 2023 | $419 | -25.7% | 123,795 | +18.4% | 0.00% | – |
| Q3 2023 | $564 | -42.8% | 104,590 | -0.3% | 0.00% | -100.0% |
| Q2 2023 | $986 | -3.3% | 104,902 | +0.6% | 0.00% | – |
| Q1 2023 | $1,020 | -23.0% | 104,248 | -1.6% | 0.00% | -100.0% |
| Q4 2022 | $1,324 | -99.9% | 105,893 | +3.7% | 0.00% | 0.0% |
| Q3 2022 | $929,000 | +254.6% | 102,163 | +0.5% | 0.00% | – |
| Q2 2022 | $262,000 | -63.7% | 101,681 | -1.1% | 0.00% | -100.0% |
| Q1 2022 | $722,000 | – | 102,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 4,214,498 | $14,245,003 | 67.78% |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $19,728,634 | 2.35% |
| Trustees of Columbia University in the City of New York | 192,973 | $652,249 | 1.38% |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1,894,811 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 535,120 | $1,808,706 | 0.29% |
| Artal Group S.A. | 1,811,191 | $6,122 | 0.20% |
| Deep Track Capital, LP | 1,594,931 | $5,390,867 | 0.18% |
| BVF INC/IL | 1,813,633 | $6,130,080 | 0.15% |
| Anson Funds Management LP | 207,016 | $699,714 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,173,523 | $3,966,508 | 0.07% |